Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 25, 2006
[Surveillance of cytomegalovirus for antiviral efficacy and risk factors in allogeneic hematopoietic stem cell transplantation]Jin-Song Jia, Dong-Ping Liu, Xiao-Jun Huang, et al.
Leukemia & Lymphoma|April 5, 2013
Early lymphocyte recovery predicts superior overall survival after unmanipulated haploidentical blood and marrow transplant for myelodysplastic syndrome and acute myeloid leukemia evolving from myelodysplastic syndromeYing-Jun Chang, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Zhonghua Nei Ke Za Zhi|February 12, 2008
[Allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia]Yu Wang, Kai-yan Liu, Lan-ping Xu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|August 21, 2010
[Safety comparison of mobilization and collection of hematopoietic stem cells between related and unrelated donors]Shen Zhang, Hui Jin, Lan-Ping Xu, et al.
Journal of Hematology & Oncology|May 17, 2020
Comparison of haplo-SCT and chemotherapy for young adults with standard-risk Ph-negative acute lymphoblastic leukemia in CR1Meng Lv, Qian Jiang, Dao-Bin Zhou, et al.
Chinese Medical Journal|March 20, 2013
Idiopathic inflammatory demyelinating diseases of the central nervous system in patients following allogeneic hematopoietic stem cell transplantation: a retrospective analysis of incidence, risk factors and survivalXiao-Hui Zhang, Xiao-Jun Huang, Kai-Yan Liu, et al.
Chinese Medical Journal|July 16, 2019
Comparison of outcomes after human leukocyte antigen-matched and haploidentical hematopoietic stem-cell transplantation for multiple myelomaYao Chen, Wei-Jun Fu, Lan-Ping Xu, et al.
International Journal of Cardiology|June 26, 2012
Heart failure after allogeneic hematopoietic stem cell transplantationXiao-Dong Mo, Lan-Ping Xu, Dai-Hong Liu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|March 7, 2014
[A new multi-factor risk score system for predicting the outcome after allogenic hematopoietic stem cell transplantation]Jing Liu, Lan-Ping Xu, Dai-Hong Liu, et al.
Zhonghua Nei Ke Za Zhi|January 19, 2013
[The efficacy and safety of rituximab in treatment of Epstein-Barr virus disease post allogeneic hematopoietic stem-cell transplantation]Lan-ping Xu, Dai-hong Liu, Kai-yan Liu, et al.
Pageof 21